Ratings by BofA Securities (Derik de Bruin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/20/2023 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2023 | Stevanato Group S.p.A. | STVN | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2023 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 1/20/2023 | Hologic | HOLX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/20/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2023 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Underperform (N/A) |
|
Details | ||
| 1/20/2023 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2023 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/4/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Hologic | HOLX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/4/2023 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 1/4/2023 | Seer Inc. | SEER | Downgrade | Underperform (Neutral) |
5.85 (4.56) |
-22.05% | Details | |
| 12/16/2022 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2022 | PerkinElmer | PKI | Maintain | Neutral (N/A) |
|
Details | ||
| 11/15/2022 | Lucira Health Inc. | LHDX | Maintain | Underperform (N/A) |
|
Details | ||
| 11/9/2022 | ICON plc | ICLR | Upgrade | Buy (Neutral) |
195.07 (223.99) |
14.83% | Details | |
| 11/4/2022 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Catalent | CTLT | Downgrade | Neutral (Buy) |
49.53 (52.58) |
6.16% | Details | |
| 10/31/2022 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2022 | West Pharmaceutical | WST | Downgrade | Neutral (Buy) |
221.23 (261.82) |
18.35% | Details | |
| 8/30/2022 | Catalent | CTLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Recursion Pharmaceuticals | RXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2022 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Singular Genomics | OMIC | Downgrade | Underperform (Buy) |
4.45 (2.48) |
-44.27% | Details | |
| 8/2/2022 | PerkinElmer | PKI | Downgrade | Neutral (Buy) |
160.87 (135.28) |
-15.91% | Details | |
| 7/20/2022 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Singular Genomics | OMIC | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Neogenomics | NEO | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2022 | Laboratory Corporation of America | LH | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2022 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2022 | 10X Genomics | TXG | Downgrade | Underperform (Neutral) |
43.29 (45.37) |
4.8% | Details | |
| 5/25/2022 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2022 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/18/2022 | Ginkgo Bioworks Holdings Inc | DNA | Downgrade | Underperform (Neutral) |
2.74 (1.82) |
-33.58% | Details | |
| 5/17/2022 | Waters Corp. | WAT | Upgrade | Neutral (Underperform) |
320.93 (324.32) |
1.06% | Details | |
| 4/29/2022 | West Pharmaceutical | WST | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2022 | Qiagen NV | QGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2022 | Laboratory Corporation of America | LH | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2022 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2022 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2022 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Recursion Pharmaceuticals | RXRX | Downgrade | Neutral (Buy) |
7.46 (8.06) |
8.04% | Details | |
| 3/9/2022 | Stevanato Group S.p.A. | STVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Seer Inc. | SEER | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2022 | Iconix Brand | ICON | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2022 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2022 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2022 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2022 | Laboratory Corporation of America | LH | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2022 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2022 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2022 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2022 | Catalent | CTLT | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2022 | Ginkgo Bioworks Holdings Inc | DNA | New Coverage | Neutral (N/A) |
4.65 (1.82) |
-60.86% | Details | |
| 1/13/2022 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2022 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 1/12/2022 | Myriad Genetics | MYGN | Maintain | Underperform (N/A) |
|
Details | ||
| 1/7/2022 | Talis Biomedical Corp. | TLIS | Downgrade | Underperform (Neutral) |
3.53 (0.58) |
-83.57% | Details | |
| 1/7/2022 | Illumina | ILMN | Upgrade | Neutral (Underperform) |
378.93 (210.10) |
-44.55% | Details | |
| 11/23/2021 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2021 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2021 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2021 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 9/29/2021 | 10X Genomics | TXG | Downgrade | Neutral (Buy) |
146.04 (45.37) |
-68.93% | Details | |
| 9/20/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | Stevanato Group S.p.A. | STVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | West Pharmaceutical | WST | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | Catalent | CTLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2021 | 10X Genomics | TXG | Downgrade | Neutral (Buy) |
169.00 (45.37) |
-73.15% | Details | |
| 9/10/2021 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2021 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2021 | Talis Biomedical Corp. | TLIS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/18/2021 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | Zymergen Inc | ZY | Downgrade | Underperform (Buy) |
34.83 (2.43) |
-93.02% | Details | |
| 8/4/2021 | Myriad Genetics | MYGN | Maintain | Underperform (N/A) |
|
Details | ||
| 8/3/2021 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2021 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2021 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2021 | Qiagen NV | QGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2021 | PerkinElmer | PKI | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2021 | Seer Inc. | SEER | Maintain | Neutral (N/A) |
|
Details | ||
| 2/17/2021 | Agilent | A | Upgrade | Buy (Neutral) |
127.95 (151.74) |
18.59% | Details | |
| 9/25/2020 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2020 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2020 | Agilent | A | Maintain | Neutral (N/A) |
|
Details | ||
| 7/29/2020 | Laboratory Corporation of America | LH | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2020 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | Quest Diagnostics | DGX | Upgrade | Buy (Neutral) |
119.14 (145.76) |
22.34% | Details | |
| 7/14/2020 | Laboratory Corporation of America | LH | Upgrade | Buy (Neutral) |
178.26 (251.12) |
40.87% | Details | |
| 7/7/2020 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2020 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2020 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 12/26/2019 | Qiagen NV | QGEN | New Coverage | Underperform (N/A) |
41.47 (48.82) |
17.72% | Details | |
| 10/17/2019 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2019 | Qiagen NV | QGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/26/2019 | Myriad Genetics | MYGN | Downgrade | Underperform (Neutral) |
29.93 (19.26) |
-35.65% | Details | |
| 9/26/2019 | Bruker | BRKR | Upgrade | Buy (Neutral) |
43.27 (69.80) |
61.31% | Details | |
| 8/2/2019 | Myriad Genetics | MYGN | Upgrade | Neutral (Underperform) |
45.01 (29.93) |
-33.5% | Details | |
| 7/16/2019 | Quest Diagnostics | DGX | Maintain | Underperform (N/A) |
|
Details | ||
| 7/16/2019 | Myriad Genetics | MYGN | Maintain | Underperform (N/A) |
|
Details | ||
| 7/16/2019 | Mettler-Toledo | MTD | Maintain | Neutral (N/A) |
|
Details | ||
| 7/16/2019 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Agilent | A | Downgrade | Neutral (Buy) |
71.65 (151.74) |
111.78% | Details | |
| 7/16/2019 | Waters Corp. | WAT | Downgrade | Underperform (Neutral) |
217.13 (324.32) |
49.37% | Details | |
| 7/16/2019 | Laboratory Corporation of America | LH | Upgrade | Neutral (Underperform) |
175.45 (251.12) |
43.13% | Details | |
| 6/21/2019 | Qiagen NV | QGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/21/2019 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 6/11/2019 | Avantor Inc. | AVTR | New Coverage | Buy (N/A) |
17.20 (23.52) |
36.74% | Details | |
| 4/10/2019 | Guardant Health | GH | Upgrade | Buy (Neutral) |
66.18 (30.87) |
-53.35% | Details | |
| 3/13/2019 | Guardant Health | GH | Maintain | Neutral (N/A) |
|
Details | ||
| 1/3/2019 | Quest Diagnostics | DGX | Downgrade | Underperform (Neutral) |
83.27 (107.21) |
28.75% | Details | |
| 1/3/2019 | Laboratory Corporation of America | LH | Downgrade | Underperform (Neutral) |
126.36 (175.45) |
38.85% | Details | |
| 1/3/2019 | Mettler-Toledo | MTD | Downgrade | Neutral (Buy) |
565.58 (1507.41) |
166.52% | Details | |
| 1/3/2019 | Waters Corp. | WAT | Upgrade | Neutral (Underperform) |
188.65 (217.13) |
15.1% | Details | |
| 12/3/2018 | Quest Diagnostics | DGX | Downgrade | Neutral (Buy) |
88.57 (83.27) |
-5.98% | Details | |
| 12/3/2018 | Laboratory Corporation of America | LH | Downgrade | Neutral (Buy) |
161.81 (126.36) |
-21.91% | Details | |
| 10/29/2018 | Guardant Health | GH | New Coverage | Neutral (N/A) |
35.14 (66.18) |
88.33% | Details | |
| 10/19/2018 | Quest Diagnostics | DGX | New Coverage | Buy (N/A) |
102.38 (88.57) |
-13.49% | Details | |
| 10/19/2018 | Laboratory Corporation of America | LH | New Coverage | Buy (N/A) |
174.09 (161.81) |
-7.05% | Details |
